BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 7705814)

  • 1. Uterine smooth muscle tumors: a multicenter, retrospective, comparative study of clinical and ultrasound features.
    Borella F; Mancarella M; Preti M; Mariani L; Stura I; Sciarrone A; Bertschy G; Leuzzi B; Piovano E; Valabrega G; Turinetto M; Pino I; Castellano I; Bertero L; Cassoni P; Cosma S; Franchi D; Benedetto C
    Int J Gynecol Cancer; 2023 Dec; ():. PubMed ID: 38054268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uterine myxoid leiomyosarcoma - a rare malignant tumor: the role of complex morphopathological assay. Review and case presentation.
    Istrate-Ofiţeru AM; Zorilă GL; Ruican D; Petrescu AM; Berbecaru EIA; Roşu GC; Căpitănescu RG; Nagy RD; Cercelaru L; Edu A; Iliescu DG; Drăguşin RC
    Rom J Morphol Embryol; 2021; 62(4):883-896. PubMed ID: 35673808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD146 as an adverse prognostic factor in uterine sarcoma.
    Zhou Y; Huang H; Yuan LJ; Xiong Y; Huang X; Lin JX; Zheng M
    Eur J Med Res; 2015 Aug; 20(1):67. PubMed ID: 26293576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uterine smooth muscle tumor analysis by comparative genomic hybridization: a useful diagnostic tool in challenging lesions.
    Croce S; Ribeiro A; Brulard C; Noel JC; Amant F; Stoeckle E; Devouassoux-Shisheborah M; Floquet A; Arnould L; Guyon F; Mishellany F; Garbay D; Cuppens T; Zikan M; Leroux A; Frouin E; Duvillard P; Terrier P; Farre I; Valo I; MacGrogan GM; Chibon F
    Mod Pathol; 2015 Jul; 28(7):1001-10. PubMed ID: 25932961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new scoring system using multiple immunohistochemical markers for diagnosis of uterine smooth muscle tumors.
    Rath-Wolfson L; Rosenblat Y; Halpern M; Herbert M; Hammel I; Gal R; Leabu M; Koren R
    J Cell Mol Med; 2006; 10(1):197-205. PubMed ID: 16563231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mouse model of uterine leiomyosarcoma.
    Politi K; Szabolcs M; Fisher P; Kljuic A; Ludwig T; Efstratiadis A
    Am J Pathol; 2004 Jan; 164(1):325-36. PubMed ID: 14695345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of immunohistochemistry for p53 in primary soft-tissue sarcomas: a multivariate analysis of five antibodies.
    Würl P; Taubert H; Meye A; Berger D; Lautenschläger C; Holzhausen HJ; Schmidt H; Kalthoff H; Rath FW; Dralle H
    J Cancer Res Clin Oncol; 1997; 123(9):502-8. PubMed ID: 9341900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical uterine leiomyoma: a case report and review of the literature.
    Manxhuka-Kerliu S; Kerliu-Saliu I; Sahatciu-Meka V; Kerliu L; Shahini L
    J Med Case Rep; 2016 Jan; 10():22. PubMed ID: 26801982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myxoid Leiomyosarcoma of the Uterus: A Clinicopathologic Analysis of 30 Cases and Review of the Literature With Reappraisal of Its Distinction From Other Uterine Myxoid Mesenchymal Neoplasms.
    Parra-Herran C; Schoolmeester JK; Yuan L; Dal Cin P; Fletcher CD; Quade BJ; Nucci MR
    Am J Surg Pathol; 2016 Mar; 40(3):285-301. PubMed ID: 26866354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 protein overexpression in smooth muscle tumors of the uterus.
    Niemann TH; Raab SS; Lenel JC; Rodgers JR; Robinson RA
    Hum Pathol; 1995 Apr; 26(4):375-9. PubMed ID: 7705814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A panel of antibodies to determine site of origin and malignancy in smooth muscle tumors.
    Lee CH; Turbin DA; Sung YC; Espinosa I; Montgomery K; van de Rijn M; Gilks CB
    Mod Pathol; 2009 Dec; 22(12):1519-31. PubMed ID: 19734847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An immunohistochemical analysis of stathmin 1 expression in uterine smooth muscle tumors: differential expression in leiomyosarcomas and leiomyomas.
    Allen MM; Douds JJ; Liang SX; Desouki MM; Parkash V; Fadare O
    Int J Clin Exp Pathol; 2015; 8(3):2795-801. PubMed ID: 26045786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of progesterone receptor, p16, p53 and pHH3 expression in uterine atypical leiomyoma.
    Liang Y; Zhang X; Chen X; Lü W
    Int J Clin Exp Pathol; 2015; 8(6):7196-202. PubMed ID: 26261614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leiomyosarcoma of the uterus: A clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases.
    Blom R; Guerrieri C; Stâl O; Malmström H; Simonsen E
    Gynecol Oncol; 1998 Jan; 68(1):54-61. PubMed ID: 9454661
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.